956
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

A second target of benzamide riboside

Dihydrofolate reductase

, , , , , , , , , & show all
Pages 1290-1298 | Received 10 May 2012, Accepted 08 Aug 2012, Published online: 06 Sep 2012

References

  • Kamen BACP, Bertino JR. Folate antagonists. Cancer medicine: BC Decker 2003:727-38.
  • Alt FW, Kellems RE, Bertino JR, Schimke RT. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem 1978; 253:1357 - 70; PMID: 627542
  • Göker E, Kheradpour A, Waltham M, Banerjee D, Tong WP, Elisseyeff Y, et al. Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate. Leukemia 1995; 9:274 - 6; PMID: 7532768
  • Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002; 1587:164 - 73; http://dx.doi.org/10.1016/S0925-4439(02)00079-0; PMID: 12084458
  • Matherly LH, Goldman DI. Membrane transport of folates. Vitam Horm 2003; 66:403 - 56; http://dx.doi.org/10.1016/S0083-6729(03)01012-4; PMID: 12852262
  • Zhao R, Diop-Bove N, Visentin M, Goldman ID. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr 2011; 31:177 - 201; http://dx.doi.org/10.1146/annurev-nutr-072610-145133; PMID: 21568705
  • Assaraf YG. Molecular basis of antifolate resistance. Cancer Metastasis Rev 2007; 26:153 - 81; http://dx.doi.org/10.1007/s10555-007-9049-z; PMID: 17333344
  • Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR. Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 1996; 335:1041 - 8; http://dx.doi.org/10.1056/NEJM199610033351408; PMID: 8793930
  • Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 2007; 104:13513 - 8; http://dx.doi.org/10.1073/pnas.0706217104; PMID: 17686970
  • Pankiewicz KW, Watanabe KA, Lesiak-Watanabe K, Goldstein BM, Jayaram HN. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. Curr Med Chem 2002; 9:733 - 41; http://dx.doi.org/10.2174/0929867024606920; PMID: 11966436
  • Sandhu SK, Yap TA, de Bono JS. The emerging role of poly(ADP-Ribose) polymerase inhibitors in cancer treatment. Curr Drug Targets 2011.; 12:2034 - 44; http://dx.doi.org/10.2174/138945011798829438; PMID: 21777194
  • Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Soto M, et al. Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy. Recent Pat Anticancer Drug Discov 2006; 1:39 - 53; http://dx.doi.org/10.2174/157489206775246430; PMID: 18221025
  • Krohn K, Dörner H, Zukowski M. Chemical synthesis of benzamide riboside. Curr Med Chem 2002; 9:727 - 31; http://dx.doi.org/10.2174/0929867024606876; PMID: 11966435
  • Jäger W, Salamon A, Szekeres T. Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside. Curr Med Chem 2002; 9:781 - 6; http://dx.doi.org/10.2174/0929867024606830; PMID: 11966442
  • Saunders PP, Arimilli S, Krohn K, Muhs MA, Alvarez E, Surve-lyer R. Metabolism and action of benzamide riboside in Chinese hamster ovary cells. Anticancer Drugs 1996; 7:93 - 9; http://dx.doi.org/10.1097/00001813-199601000-00011; PMID: 8742104
  • Gharehbaghi K, Grünberger W, Jayaram HN. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase. Curr Med Chem 2002; 9:743 - 8; http://dx.doi.org/10.2174/0929867024606902; PMID: 11966437
  • Hsieh Y-C, Lawal RAL, Scotto K, Banerjee D, Ercikan Abali E, Bertino JR. Targeting the NADPH binding site of dihydrofolate reductase for cancer therapy AACR Meeting Abstracts 2010; 2010.
  • Perkins JP, Bertino JR. Dihydrofolate reductase from the L1210R murine lymphoma. Fluorometric measurements of the interaction of the enzyme with coenzymes, substrates, and inhibitors. Biochemistry 1966; 5:1005 - 12; http://dx.doi.org/10.1021/bi00867a028; PMID: 4380350
  • Hakala MT, Suolinna EM. Specific protection of folate reductase against chemical and proteolytic inactivation. Mol Pharmacol 1966; 2:465 - 80; PMID: 6008166
  • Bonnac L, Chen L, Pathak R, Gao G, Ming Q, Bennett E, et al. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues. Bioorg Med Chem Lett 2007; 17:1512 - 5; http://dx.doi.org/10.1016/j.bmcl.2007.01.012; PMID: 17258457
  • Peñuelas S, Noé V, Ciudad CJ. Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. FEBS J 2005; 272:696 - 710; http://dx.doi.org/10.1111/j.1742-4658.2004.04504.x; PMID: 15670151
  • Yalowitz JA, Jayaram HN. Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase. Curr Med Chem 2002; 9:749 - 58; http://dx.doi.org/10.2174/0929867024606867; PMID: 11966438
  • Jayaram HN, Yalowitz JA, Arguello F, Greene JF Jr.. Toxicity and efficacy of benzamide riboside in cancer chemotherapy models. Curr Med Chem 2002; 9:787 - 92; http://dx.doi.org/10.2174/0929867024606858; PMID: 11966443
  • Mini E, Moroson BA, Franco CT, Bertino JR. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines. Cancer Res 1985; 45:325 - 30; PMID: 3855284
  • Skacel N, Menon LG, Mishra PJ, Peters R, Banerjee D, Bertino JR, et al. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment. J Biol Chem 2005; 280:22721 - 31; http://dx.doi.org/10.1074/jbc.M500277200; PMID: 15817466
  • Felczak K, Pankiewicz KW. Synthesis of methylenebis(phosphonate) analogues of 2-, 4-, and 6-pyridones of nicotinamide adenine dinucleotide. Nucleosides Nucleotides Nucleic Acids 2011; 30:512 - 23; http://dx.doi.org/10.1080/15257770.2011.575909; PMID: 21888543

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.